Synthesis of new camptothecin analogs with improved antitumor activities. 2009

Satoshi Niizuma, and Masao Tsukazaki, and Hitomi Suda, and Takeshi Murata, and Jun Ohwada, and Sawako Ozawa, and Hiroshi Fukuda, and Chikako Murasaki, and Masami Kohchi, and Kenji Morikami, and Kiyoshi Yoshinari, and Mika Endo, and Masako Ura, and Hiromi Tanimura, and Yoko Miyazaki, and Tsuyoshi Takasuka, and Akira Kawashima, and Eitaro Nanba, and Kounosuke Nakano, and Kotaro Ogawa, and Kazuko Kobayashi, and Hisafumi Okabe, and Isao Umeda, and Nobuo Shimma
Kamakura Research Laboratories, Chugai Pharmaceutical Co., Ltd, 200 Kajiwara, Kamakura, Kanagawa 247-8530, Japan.

Novel hexacyclic camptothecin analogs containing cyclic amidine, urea, or thiourea moiety were designed and synthesized based on the proposed 3D-structure of the topoisomerase I (Topo I)/DNA/camptothecin ternary complex. The analogs were prepared from 9-nitrocamptothecin via 7,9-diaminocamptothecin derivatives as a key intermediate. Among them, 7c exhibited in vivo antitumor activities superior to CPT-11 in human cancer xenograft models in mice at their maximum tolerated doses though its in vitro antiproliferative activity was comparable to SN-38 against corresponding cell lines.

UI MeSH Term Description Entries
D002166 Camptothecin An alkaloid isolated from the stem wood of the Chinese tree, Camptotheca acuminata. This compound selectively inhibits the nuclear enzyme DNA TOPOISOMERASES, TYPE I. Several semisynthetic analogs of camptothecin have demonstrated antitumor activity. Camptothecine
D004264 DNA Topoisomerases, Type I DNA TOPOISOMERASES that catalyze ATP-independent breakage of one of the two strands of DNA, passage of the unbroken strand through the break, and rejoining of the broken strand. DNA Topoisomerases, Type I enzymes reduce the topological stress in the DNA structure by relaxing the superhelical turns and knotted rings in the DNA helix. DNA Nicking-Closing Protein,DNA Relaxing Enzyme,DNA Relaxing Protein,DNA Topoisomerase,DNA Topoisomerase I,DNA Topoisomerase III,DNA Topoisomerase III alpha,DNA Topoisomerase III beta,DNA Untwisting Enzyme,DNA Untwisting Protein,TOP3 Topoisomerase,TOP3alpha,TOPO IIIalpha,Topo III,Topoisomerase III,Topoisomerase III beta,Topoisomerase IIIalpha,Topoisomerase IIIbeta,DNA Nicking-Closing Proteins,DNA Relaxing Enzymes,DNA Type 1 Topoisomerase,DNA Untwisting Enzymes,DNA Untwisting Proteins,Topoisomerase I,Type I DNA Topoisomerase,III beta, Topoisomerase,III, DNA Topoisomerase,III, Topo,III, Topoisomerase,IIIalpha, TOPO,IIIalpha, Topoisomerase,IIIbeta, Topoisomerase,Topoisomerase III, DNA,Topoisomerase, TOP3,beta, Topoisomerase III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014183 Transplantation, Heterologous Transplantation between animals of different species. Xenotransplantation,Heterograft Transplantation,Heterografting,Heterologous Transplantation,Xenograft Transplantation,Xenografting,Transplantation, Heterograft,Transplantation, Xenograft
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D059004 Topoisomerase I Inhibitors Compounds that inhibit the activity of DNA TOPOISOMERASE I. DNA Topoisomerase I Inhibitor,DNA Topoisomerase III Inhibitor,DNA Topoisomerase III Inhibitors,DNA Type 1 Topoisomerase Inhibitor,DNA Type III Topoisomerase Inhibitor,DNA Type III Topoisomerase Inhibitors,Topoisomerase 1 Inhibitor,Topoisomerase 1 Inhibitors,Topoisomerase 3 Inhibitor,Topoisomerase 3 Inhibitors,Topoisomerase I Inhibitor,Topoisomerase III Inhibitor,Topoisomerase III Inhibitors,DNA Topoisomerase I Inhibitors,DNA Type 1 Topoisomerase Inhibitors,1 Inhibitor, Topoisomerase,3 Inhibitor, Topoisomerase,3 Inhibitors, Topoisomerase,I Inhibitor, Topoisomerase,III Inhibitor, Topoisomerase,III Inhibitors, Topoisomerase,Inhibitor, Topoisomerase 1,Inhibitor, Topoisomerase 3,Inhibitor, Topoisomerase I,Inhibitor, Topoisomerase III,Inhibitors, Topoisomerase 1,Inhibitors, Topoisomerase 3,Inhibitors, Topoisomerase I,Inhibitors, Topoisomerase III

Related Publications

Satoshi Niizuma, and Masao Tsukazaki, and Hitomi Suda, and Takeshi Murata, and Jun Ohwada, and Sawako Ozawa, and Hiroshi Fukuda, and Chikako Murasaki, and Masami Kohchi, and Kenji Morikami, and Kiyoshi Yoshinari, and Mika Endo, and Masako Ura, and Hiromi Tanimura, and Yoko Miyazaki, and Tsuyoshi Takasuka, and Akira Kawashima, and Eitaro Nanba, and Kounosuke Nakano, and Kotaro Ogawa, and Kazuko Kobayashi, and Hisafumi Okabe, and Isao Umeda, and Nobuo Shimma
July 2004, Yao xue xue bao = Acta pharmaceutica Sinica,
Satoshi Niizuma, and Masao Tsukazaki, and Hitomi Suda, and Takeshi Murata, and Jun Ohwada, and Sawako Ozawa, and Hiroshi Fukuda, and Chikako Murasaki, and Masami Kohchi, and Kenji Morikami, and Kiyoshi Yoshinari, and Mika Endo, and Masako Ura, and Hiromi Tanimura, and Yoko Miyazaki, and Tsuyoshi Takasuka, and Akira Kawashima, and Eitaro Nanba, and Kounosuke Nakano, and Kotaro Ogawa, and Kazuko Kobayashi, and Hisafumi Okabe, and Isao Umeda, and Nobuo Shimma
September 2017, European journal of medicinal chemistry,
Satoshi Niizuma, and Masao Tsukazaki, and Hitomi Suda, and Takeshi Murata, and Jun Ohwada, and Sawako Ozawa, and Hiroshi Fukuda, and Chikako Murasaki, and Masami Kohchi, and Kenji Morikami, and Kiyoshi Yoshinari, and Mika Endo, and Masako Ura, and Hiromi Tanimura, and Yoko Miyazaki, and Tsuyoshi Takasuka, and Akira Kawashima, and Eitaro Nanba, and Kounosuke Nakano, and Kotaro Ogawa, and Kazuko Kobayashi, and Hisafumi Okabe, and Isao Umeda, and Nobuo Shimma
November 1971, Journal of medicinal chemistry,
Satoshi Niizuma, and Masao Tsukazaki, and Hitomi Suda, and Takeshi Murata, and Jun Ohwada, and Sawako Ozawa, and Hiroshi Fukuda, and Chikako Murasaki, and Masami Kohchi, and Kenji Morikami, and Kiyoshi Yoshinari, and Mika Endo, and Masako Ura, and Hiromi Tanimura, and Yoko Miyazaki, and Tsuyoshi Takasuka, and Akira Kawashima, and Eitaro Nanba, and Kounosuke Nakano, and Kotaro Ogawa, and Kazuko Kobayashi, and Hisafumi Okabe, and Isao Umeda, and Nobuo Shimma
January 2013, Journal of Asian natural products research,
Satoshi Niizuma, and Masao Tsukazaki, and Hitomi Suda, and Takeshi Murata, and Jun Ohwada, and Sawako Ozawa, and Hiroshi Fukuda, and Chikako Murasaki, and Masami Kohchi, and Kenji Morikami, and Kiyoshi Yoshinari, and Mika Endo, and Masako Ura, and Hiromi Tanimura, and Yoko Miyazaki, and Tsuyoshi Takasuka, and Akira Kawashima, and Eitaro Nanba, and Kounosuke Nakano, and Kotaro Ogawa, and Kazuko Kobayashi, and Hisafumi Okabe, and Isao Umeda, and Nobuo Shimma
September 1993, Journal of medicinal chemistry,
Satoshi Niizuma, and Masao Tsukazaki, and Hitomi Suda, and Takeshi Murata, and Jun Ohwada, and Sawako Ozawa, and Hiroshi Fukuda, and Chikako Murasaki, and Masami Kohchi, and Kenji Morikami, and Kiyoshi Yoshinari, and Mika Endo, and Masako Ura, and Hiromi Tanimura, and Yoko Miyazaki, and Tsuyoshi Takasuka, and Akira Kawashima, and Eitaro Nanba, and Kounosuke Nakano, and Kotaro Ogawa, and Kazuko Kobayashi, and Hisafumi Okabe, and Isao Umeda, and Nobuo Shimma
August 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V,
Satoshi Niizuma, and Masao Tsukazaki, and Hitomi Suda, and Takeshi Murata, and Jun Ohwada, and Sawako Ozawa, and Hiroshi Fukuda, and Chikako Murasaki, and Masami Kohchi, and Kenji Morikami, and Kiyoshi Yoshinari, and Mika Endo, and Masako Ura, and Hiromi Tanimura, and Yoko Miyazaki, and Tsuyoshi Takasuka, and Akira Kawashima, and Eitaro Nanba, and Kounosuke Nakano, and Kotaro Ogawa, and Kazuko Kobayashi, and Hisafumi Okabe, and Isao Umeda, and Nobuo Shimma
June 1995, The Journal of antibiotics,
Satoshi Niizuma, and Masao Tsukazaki, and Hitomi Suda, and Takeshi Murata, and Jun Ohwada, and Sawako Ozawa, and Hiroshi Fukuda, and Chikako Murasaki, and Masami Kohchi, and Kenji Morikami, and Kiyoshi Yoshinari, and Mika Endo, and Masako Ura, and Hiromi Tanimura, and Yoko Miyazaki, and Tsuyoshi Takasuka, and Akira Kawashima, and Eitaro Nanba, and Kounosuke Nakano, and Kotaro Ogawa, and Kazuko Kobayashi, and Hisafumi Okabe, and Isao Umeda, and Nobuo Shimma
January 1990, Yao xue xue bao = Acta pharmaceutica Sinica,
Satoshi Niizuma, and Masao Tsukazaki, and Hitomi Suda, and Takeshi Murata, and Jun Ohwada, and Sawako Ozawa, and Hiroshi Fukuda, and Chikako Murasaki, and Masami Kohchi, and Kenji Morikami, and Kiyoshi Yoshinari, and Mika Endo, and Masako Ura, and Hiromi Tanimura, and Yoko Miyazaki, and Tsuyoshi Takasuka, and Akira Kawashima, and Eitaro Nanba, and Kounosuke Nakano, and Kotaro Ogawa, and Kazuko Kobayashi, and Hisafumi Okabe, and Isao Umeda, and Nobuo Shimma
November 2009, Bioorganic & medicinal chemistry letters,
Satoshi Niizuma, and Masao Tsukazaki, and Hitomi Suda, and Takeshi Murata, and Jun Ohwada, and Sawako Ozawa, and Hiroshi Fukuda, and Chikako Murasaki, and Masami Kohchi, and Kenji Morikami, and Kiyoshi Yoshinari, and Mika Endo, and Masako Ura, and Hiromi Tanimura, and Yoko Miyazaki, and Tsuyoshi Takasuka, and Akira Kawashima, and Eitaro Nanba, and Kounosuke Nakano, and Kotaro Ogawa, and Kazuko Kobayashi, and Hisafumi Okabe, and Isao Umeda, and Nobuo Shimma
April 2009, Archiv der Pharmazie,
Copied contents to your clipboard!